People · Operator

Charles H. Burns

Named in public records as an officer, director or promoter · active 2017–2020 · Biotechnology

1
Companies
4
Filings
$2.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Jupiter Biomedical Research, Inc.BiotechnologyPre-Seed$2.1M$844K2017
Operator network

Charles H. Burns at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David C. Vaughan · 1 companies · 1 sharedDavid C. VaughanFrank Gerardi · 1 companies · 1 sharedFrank GerardiFrank H. Gerardi · 1 companies · 1 sharedFrank H. GerardiJohn C. Fanaras · 1 companies · 1 sharedJohn C. FanarasJohn H. Fanaras · 1 companies · 1 sharedJohn H. FanarasKingsley C. Ward · 1 companies · 1 sharedKingsley C. WardRichard H. Tambone · 1 companies · 1 sharedRichard H. TamboneRichard P. Tambone · 1 companies · 1 sharedRichard P. TamboneRobert C. Hackney · 1 companies · 1 sharedRobert C. HackneyTipton C. Shonkwiler · 1 companies · 1 sharedTipton C. Shonkwi…Viviam G. Tucker · 1 companies · 1 sharedViviam G. TuckerVivian G. Tucker · 1 companies · 1 sharedVivian G. TuckerWilliam G. Tucker · 1 companies · 1 sharedWilliam G. TuckerJupiter Biomedical Research, Inc. · $2.1M raisedJupiter Biomedical Re…Charles H. BurnsCB
Charles H. Burns Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Charles H. Burns on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Frank Gerardi11
John C. Fanaras11
Tipton C. Shonkwiler11
David C. Vaughan11
Robert C. Hackney11
Richard P. Tambone11
William G. Tucker11
Kingsley C. Ward11
John H. Fanaras11
Frank H. Gerardi11
Richard H. Tambone11
Vivian G. Tucker11
Viviam G. Tucker11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.